February 28, 2025

New Member: Welcome in our cluster to CAVIGEN UG

New Member: Welcome in our cluster to CAVIGEN UG
Go back

CAVIGEN develops thermoformed microstructures for cell culture, including microcavities, porous microcavities, sensor-integrated microcavities (sensor arrays), and microchannels. Its patented technology enables precise oxygen measurement in 3D cell cultures, enhancing the physiological relevance of in vitro models, improving drug development processes, and reducing the need for animal testing.

CAVIGEN’s business model follows a razor-and-blade approach, offering a measurement device alongside disposable sensor arrays for organoid generation and analysis. In addition, the company provides custom development services to integrate its microstructures into existing systems.

Target customers include pharmaceutical companies, CROs, biotech firms, and organ-on-chip manufacturers developing advanced in vitro models. Currently preparing for market entry, CAVIGEN is testing its first prototypes with academic research groups and industry partners while actively seeking strategic partners and investors to accelerate adoption within the pharmaceutical sector.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
Molecular signature linked to aggressive growth of head and neck tumors discovered

Molecular signature linked to aggressive growth of head and neck tumors discovered

Researchers from Heidelberg University’s Faculty of Medicine and the Technical University of Munich have investigated the genetic activity of “budding” head and neck carcinomas. In the “buds”—clusters of cells that detach from the tumor and are associated with a poor prognosis—they found a characteristic pattern of gene activity. This marker signature provides insights into the […]

read more
BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering

BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering

BioMed X, a leading innovation hub for pharma, has officially launched its first research team at BioMed X France, marking the establishment of its presence in one of Europe’s fastest-growing life science ecosystems. The new team, Team ADB (AI-Empowered Design of Bispecific Antibodies), is based within the XSeed Labs incubator on the R&D campus of Servier in […]

read more
Mapping the microbial communities beneath our feet and inside our guts

Mapping the microbial communities beneath our feet and inside our guts

MGnify Genomes offers new ways to explore microbial communities in soil, marine sediments, and the gut If you could shrink yourself to the size of a microbe, you would discover that every handful of soil and every bucket of seawater is akin to a bustling city filled with millions of microbes. Until recently, most of […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp